COSCIENS Biopharma Inc. Reports Third Quarter 2025 Financial Results and Provides Strategic Initiatives Update
COSCIENS voluntarily delists from Nasdaq, while retaining the Company's listing on the TSX COSCIENS restructuring results in significantly lower cash outflow with operating expenses down 59% vs. Q3 2024. TORONTO, ONTARIO, Nov. 11, 2025 (GLOBE NEWSWIRE) — COSC
(Financial Post, 2025-11-11T22:18:40Z)